ACU Reports Q2 2026 Earnings Beat Driven by MyMedic Acquisition and Margin Recovery

• Acme United reported Q2 2026 EPS of $1.22, significantly beating analyst estimates of $0.81 by 50.6% positive surprise
• Revenue reached $62.72 million, a 16% year-over-year increase fueled by the MyMedic acquisition.
• Gross margins expanded to 42.6%, up from 41.0% in the prior year period.
• Management anticipates continued margin recovery as lower-cost inventory replaces higher-tariff stock.

Acme United Corporation (ACU) delivered robust second-quarter 2026 results, significantly outperforming market expectations across key financial metrics. The company reported earnings per share (EPS) of $1.22, which surpassed analyst estimates of $0.81 by a substantial margin. This performance represents a 50.62% positive surprise, underscoring the company's operational strength and strategic execution during the quarter.

Revenue growth was equally impressive, reaching $62.72 million compared to the forecasted $58.08 million. This top-line growth of 7.99% above estimates was driven by a 16% year-over-year increase in sales. The acquisition of MyMedic played a pivotal role in this expansion, contributing significantly to the overall revenue figures.

On an organic basis, excluding the impacts of the acquisition, sales growth remained solid at 8%. This indicates that the core business continues to perform well independently of recent M&A activity. The stock market reacted positively to these results, with the share price surging 17.52% following the earnings release.

How Did the MyMedic Acquisition Impact Acme United's Growth?

The integration of MyMedic has become a central pillar of Acme United's growth strategy, particularly in the first aid and safety segment. This strategic acquisition allows the company to significantly expand its product offerings and broaden its direct-to-consumer sales capabilities. MyMedic's strong presence in tactical and emergency response markets complements Acme United's traditional footprint.

Management is actively working to integrate MyMedic beyond its direct-to-consumer roots into mass retail channels. This expansion is expected to drive strong profitability in the fourth quarter, driven by seasonal demand. The company views the first aid and safety segment as offering higher growth potential and recurring revenue opportunities compared to its traditional cutting tools business.

The integration process also involves leveraging Acme United's existing infrastructure to scale operations and improve profitability. By combining MyMedic's brand recognition with the company's distribution network, Acme United aims to capture a larger share of the emergency response market. This move is part of a broader strategy to diversify revenue streams and reduce reliance on cyclical cutting tools.

What Are the Key Drivers Behind Margin Recovery and Future Outlook?

A key highlight of the quarter was the expansion of gross margins to 42.6%, marking a record high for the company. This improvement from 41.0% in the prior year reflects better operational efficiency and a favorable product mix. Management attributes this margin expansion to the successful integration of higher-margin products and effective cost management.

Looking ahead, CEO Johnsen outlined a strategy focused on sustained margin recovery. The company expects tariff pressures to ease as lower-cost inventory replaces higher-tariff stock throughout the remainder of the year. This inventory transition is expected to further boost profitability and support the company's financial targets.

The company is also making strategic investments in automation and new product lines to enhance long-term growth. These investments are designed to improve operational efficiency and support the company's goal of reaching $300 million in revenue within three years. The expansion into international markets, particularly Europe, is also expected to contribute to this growth trajectory.

What Risks and Challenges Should Investors Monitor?

Despite the positive outlook, investors should be aware of several potential risks. Selling, general, and administrative (SG&A) expenses remain elevated at 32% of sales, which could pressure net profitability if not managed effectively. The company faces ongoing headwinds from potential tariff and freight cost fluctuations, which could impact margins in the future.

Currency volatility and uneven geographic performance also pose risks to the business. The Canadian market, in particular, is currently lagging behind other regions, which may affect overall revenue growth. Investors should monitor these factors closely as they assess the company's long-term investment potential.

Analyst sentiment remains mixed but cautious, with some maintaining a Buy rating while others express concern over valuation. The next earnings report is scheduled for October 20, 2026, with EPS estimates at $0.67. The company currently pays an annual dividend of $0.64, yielding 1.03%, providing modest income to shareholders.